Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST(2) in Mediating Ligand Effects

SIMPLE SUMMARY: First-generation somatostatin receptor ligands, such as octreotide, are the first-line medical therapy in acromegaly. Octreotide shows preferential binding for somatostatin receptor subtype 2 (SST(2)), while the second-generation ligand, pasireotide, has high affinity for multiple SS...

Descripción completa

Detalles Bibliográficos
Autores principales: Amarù, Jessica, Barbieri, Federica, Arvigo, Marica, Solari, Agnese, Bajetto, Adriana, Nista, Federica, Campana, Claudia, Gaggero, Gabriele, Prior, Alessandro, Criminelli Rossi, Diego, Zona, Gianluigi, Ferone, Diego, Florio, Tullio, Gatto, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069349/
https://www.ncbi.nlm.nih.gov/pubmed/33920241
http://dx.doi.org/10.3390/cancers13081816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069349/
https://www.ncbi.nlm.nih.gov/pubmed/33920241
http://dx.doi.org/10.3390/cancers13081816

Ejemplares similares